LEADOPTIK

Early clinical results show that the LIA™ system enables real-time microstructure imaging to guide lung biopsies with improved precision. The technology has demonstrated potential to increase diagnostic yield and reduce errors in sampling small or peripheral lung nodules. Clinical collaborations are ongoing with leading academic centers such as Stanford Medicine to validate performance and support regulatory approval. The company has been awarded key patents across North America, Europe, and Asia for its proprietary metasurface-based miniature optical probes. No commercial sales or pivotal trial data published as of June 2025.